Artificial Intelligence-Driven Target Identification in CKD
Chanchal Kumar(Vignana Jyothi Institute of Management), Pernille Hansen(AstraZeneca (United Kingdom)), Maria Ryaboshapkina(AstraZeneca (Sweden)), Mark Davies(European Bioinformatics Institute), Iain MacPhee(St George's, University of London), Natalie Kurbatova(AstraZeneca (United Kingdom)), Claus Bendtsen(Quantitative BioSciences), Andrés Mori(BenevolentAI (United Kingdom)), Mohammad Bohlooly(AstraZeneca (Sweden)), Andrea Taddei(BenevolentAI (United Kingdom)), Lisa Buvall(AstraZeneca (United Kingdom)), Regina Fritsche‐Danielson(AstraZeneca (Sweden)), James B. Dunbar(Pfizer (United States)), Kevin Woollard(AstraZeneca (United Kingdom)), Julie Williams(University Of Bristol Dental Hospital), Dirk S. Paul(AstraZeneca (United Kingdom)), Anna Reznichenko(AstraZeneca (Sweden)), Siobhan McMahon(University of Minnesota)
Cited by 0
Related Papers
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
|Science|2009|4.1k
The ChEMBL database in 2017
|Nucleic Acids Research|2016|2.5k
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
|Science Signaling|2010|1.5k